Kalaris Therapeutics, Inc.
KLRS
$4.90
-$0.32-6.13%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 53.23% | -12.92% | -12.42% | 6,060.16% | -14.32% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -30.15% | -63.29% | 165.00% | 25.85% | 313.25% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 51.96% | -14.69% | -10.31% | 3,821.03% | 21.38% |
|
|
|||||
| Total Current Assets | 51.96% | -14.69% | -10.31% | 3,821.03% | 21.38% |
| Net Property, Plant & Equipment | -2.70% | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -1.63% | 23.93% | 30.88% | -74.41% | 1,032.48% |
| Total Assets | 49.97% | -12.57% | -9.94% | 1,573.03% | 150.39% |
|
|
|||||
| Total Accounts Payable | 159.31% | -86.58% | 55.01% | 52.18% | -29.98% |
| Total Accrued Expenses | 56.25% | 35.68% | -15.62% | 111.36% | 246.85% |
| Short-term Debt | -- | -- | -- | -- | 115.13% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -15.96% | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -38.26% | -78.90% | -34.57% |
| Total Other Current Liabilities | -- | -- | -38.26% | -78.90% | -34.57% |
| Total Current Liabilities | 60.16% | -20.73% | 7.13% | -71.09% | 79.45% |
|
|
|||||
| Total Current Liabilities | 60.16% | -20.73% | 7.13% | -71.09% | 79.45% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | 115.13% |
| Capital Leases | -3.17% | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Liabilities | 9.19% | -1.05% | 1.30% | -30.93% | 23.86% |
|
|
|||||
| Common Stock & APIC | 24.47% | 0.33% | 0.31% | 855.78% | 286.91% |
| Retained Earnings | -6.67% | -8.61% | -8.95% | -8.75% | -23.30% |
| Treasury Stock & Other | 0.00% | -- | -- | -- | -- |
| Total Common Equity | 88.26% | -21.18% | -16.84% | 166.11% | -8.10% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 0.00% |
|
|
|||||
| Total Common Equity | 88.26% | -21.18% | -16.84% | 166.11% | -8.10% |
| Total Preferred Equity | -- | -- | -- | -- | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 88.26% | -21.18% | -16.84% | 226.19% | -16.68% |
|
|
|||||